Have your own idea? Try our Stock Screener
Singaporean (SGX) Healthcare Sector Analysis
UpdatedApr 01, 2026
DataAggregated Company Financials
Companies29
- 7D0.4%
- 3M-2.2%
- 1Y16.0%
- YTD-5.3%
In the last week, the Healthcare industry is up 2.0%, with Haw Par up 6.0%. In the same time, UltraGreen.ai was down 7.1%. This takes the industry's 12 month performance to a gain of 15%. Looking forward, earnings are forecast to grow by 26% annually.
Sector Valuation and Performance
Has the Singaporean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 01 Apr 2026 | S$11.5b | S$3.2b | S$351.5m | 15.8x | 32.8x | 3.6x |
| Fri, 27 Feb 2026 | S$10.2b | S$3.1b | S$293.9m | 16.9x | 34.6x | 3.3x |
| Sun, 25 Jan 2026 | S$10.3b | S$3.1b | S$294.7m | 15.6x | 35x | 3.4x |
| Tue, 23 Dec 2025 | S$9.7b | S$3.1b | S$295.4m | 15.4x | 32.8x | 3.1x |
| Thu, 20 Nov 2025 | S$9.5b | S$3.1b | S$294.7m | 15.4x | 32.1x | 3.1x |
| Sat, 18 Oct 2025 | S$9.4b | S$3.1b | S$305.2m | 15.8x | 30.7x | 3x |
| Mon, 15 Sep 2025 | S$9.9b | S$3.2b | S$351.0m | 15.6x | 28.1x | 3.1x |
| Wed, 13 Aug 2025 | S$9.3b | S$3.1b | S$360.7m | 13.7x | 25.8x | 3.1x |
| Fri, 11 Jul 2025 | S$8.9b | S$3.1b | S$373.5m | 12.4x | 23.7x | 2.9x |
| Sun, 08 Jun 2025 | S$8.6b | S$3.1b | S$373.2m | 12.1x | 23x | 2.8x |
| Tue, 06 May 2025 | S$8.9b | S$3.1b | S$374.1m | 12.5x | 23.8x | 2.9x |
| Thu, 03 Apr 2025 | S$9.2b | S$3.1b | S$372.8m | 12.8x | 24.7x | 3x |
| Sat, 01 Mar 2025 | S$9.0b | S$3.1b | S$358.4m | 13.8x | 25.3x | 2.9x |
| Mon, 27 Jan 2025 | S$8.8b | S$3.0b | S$351.4m | 16.5x | 25x | 2.9x |
| Wed, 25 Dec 2024 | S$8.7b | S$3.0b | S$349.9m | 16.5x | 24.9x | 2.9x |
| Fri, 22 Nov 2024 | S$8.8b | S$3.0b | S$349.7m | 16.6x | 25.2x | 3x |
| Sun, 20 Oct 2024 | S$8.7b | S$2.9b | S$359.9m | 16.4x | 24.1x | 2.9x |
| Tue, 17 Sep 2024 | S$8.6b | S$3.0b | S$362.7m | 16.6x | 23.8x | 2.9x |
| Thu, 15 Aug 2024 | S$8.4b | S$2.9b | S$342.3m | 16.6x | 24.4x | 2.9x |
| Sat, 13 Jul 2024 | S$8.9b | S$2.9b | S$364.9m | 17.3x | 24.5x | 3.1x |
| Mon, 10 Jun 2024 | S$8.6b | S$2.9b | S$364.7m | 17.1x | 23.7x | 3x |
| Wed, 08 May 2024 | S$8.3b | S$2.9b | S$357.8m | 15.4x | 23.3x | 2.9x |
| Fri, 05 Apr 2024 | S$8.6b | S$2.9b | S$358.0m | 15.3x | 23.9x | 3x |
| Sun, 03 Mar 2024 | S$8.3b | S$2.9b | S$406.5m | 15.2x | 20.5x | 2.9x |
| Tue, 30 Jan 2024 | S$8.9b | S$3.2b | S$441.5m | 14.5x | 20.3x | 2.8x |
| Thu, 28 Dec 2023 | S$9.3b | S$3.2b | S$441.3m | 15.4x | 21x | 2.9x |
| Sat, 25 Nov 2023 | S$12.2b | S$4.4b | S$579.2m | 15.7x | 21x | 2.8x |
| Mon, 23 Oct 2023 | S$11.9b | S$4.4b | S$595.3m | 15.8x | 19.9x | 2.7x |
| Wed, 20 Sep 2023 | S$12.6b | S$4.4b | S$598.5m | 16.1x | 21x | 2.9x |
| Fri, 18 Aug 2023 | S$12.9b | S$4.4b | S$649.4m | 16x | 19.8x | 2.9x |
| Sun, 16 Jul 2023 | S$13.4b | S$4.5b | S$650.0m | 16x | 20.7x | 3x |
| Tue, 13 Jun 2023 | S$13.9b | S$4.5b | S$652.0m | 15.2x | 21.2x | 3.1x |
| Thu, 11 May 2023 | S$14.2b | S$4.5b | S$656.1m | 14.8x | 21.6x | 3.1x |
| Sat, 08 Apr 2023 | S$13.9b | S$4.6b | S$634.7m | 14.9x | 22x | 3x |
Price to Earnings Ratio
22x
Current Industry PE
- Investors are optimistic on the Singaporean Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 32.9x which is higher than its 3-year average PE of 24.7x.
- The 3-year average PS ratio of 3.0x is lower than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 18% per year over the last three years,
- Revenues have also declined 11% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Singaporean Healthcare sector?
| SG Market | 0.54% | |
| Healthcare | 0.38% | |
| Pharma | 5.42% | |
| Healthcare Services | -0.25% | |
| Medical Equipment | -4.39% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 18.3%, which is higher than its past year's earnings decline of 18.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 55% over the next 5 years.
- This is better than its past earnings growth rate of 13% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 4.0% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| H02 Haw Par | S$16.99 | 1.0% +S$37.6m | 28.9% | PE14.2x | |
| AP4 Riverstone Holdings | S$0.70 | 2.9% +S$29.6m | -22.7% | PE15.7x | |
| BSL Raffles Medical Group | S$1.01 | 1.5% +S$27.6m | 2.5% | PE26.3x | |
| A50 Thomson Medical Group | S$0.056 | 1.8% +S$26.4m | 21.7% | PS3.2x | |
| 40T ISEC Healthcare | S$0.34 | 6.3% +S$11.5m | -10.5% | PE14.6x |